CBUS - NASDAQ
Cibus, Inc.
$1.40
-1.1%Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.
At a Glance
Live Snapshotcbus
Cash at Beginning of Period
Last Annual Value
14.43M
3-Year CAGR
%
5-Year CAGR
-25%
10-Year CAGR
47%
Cibus, Inc. Competitors Analysis of Cash at Beginning of Period
| Company | Cash at Beginning of Period | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
 Cibus, Inc. NASDAQ:CBUS | 14.43M | 60.0% | -4.6% | -5.2% | |
 PMV Pharmaceuticals, Inc. NASDAQ:PMVP | 40.88M | -27.9% | -35.3% | N/A | |
 CervoMed Inc. NASDAQ:CRVO | 7.79M | 23.9% | -15.9% | 14.6% | |
 Werewolf Therapeutics, Inc. NASDAQ:HOWL | 112.22M | -4.9% | 3.9% | N/A | |
 Lite Strategy, Inc. NASDAQ:LITS | 3.71M | -38.3% | -21.4% | N/A | |
 XBiotech Inc. NASDAQ:XBIT | 172.68M | 3.2% | -6.2% | 6.6% | |
 Quantum-Si incorporated NASDAQ:QSI | 49.24M | -16.4% | 5.9% | N/A | |
 Unicycive Therapeutics, Inc. NASDAQ:UNCY | 26.14M | 285.9% | N/A | N/A | |
 MediciNova, Inc. NASDAQ:MNOV | 40.36M | 29.7% | -7.6% | 6.2% | |
 Biomea Fusion, Inc. NASDAQ:BMEA | 58.65M | -19.5% | -1.0% | N/A | |
 CAMP4 Therapeutics Corporation NASDAQ:CAMP | 65.66M | -8.1% | -7.0% | -7.3% |
Cibus, Inc. Fair Value Envelope
Related Guides
Continue your CBUS research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.